THEMIS, a fast-growing specialist in contractual medical malpractice indemnity, has signed a five-year capacity agreement to broaden access to its products and services.
THEMIS, a managing general agent that specialises in contractual medical malpractice indemnity, has announced a five-year capacity agreement with the multinational general insurance and reinsurance company QBE.
The five-year capacity agreement will provide THEMIS with dedicated capacity as it accelerates its UK presence and targets international expansion for underwriting clinical risks.
“This partnership with QBE represents a major step forward in our mission to provide the market with stable, reliable and innovative contractual indemnity solutions,” said George Maughan, head of client relations at THEMIS.
“Our shared vision for the future of medical malpractice insurance underpins our strategy to deliver value not only in the UK but also globally,” he continued.
Doug Walker, portfolio manager – medical malpractice and healthcare practice leader at QBE, commented: “We are proud to partner with THEMIS, whose forward-thinking approach and strong market results align perfectly with our commitment to delivering secure and sustainable solutions.”
THEMIS’s market differentiation has largely been driven by its proprietary AI-powered underwriting technology, which combines advanced machine learning with expert human oversight. This unique underwriting intelligence not only enhances precision in risk assessment and pricing accuracy but has also significantly fuelled the company’s growth to date.
This agreement demonstrates THEMIS’s long-term commitment to the market, aligned closely with its mission to provide healthcare providers with a robust contractual alternative to discretionary indemnity for a competitive premium. With the announcement of this new deal, THEMIS is strongly positioned as a leading contender in this evolving landscape.
